These innate cell changes subsequently increased pro-inflammatory cytokine secretion and recruitment of CD8+ T cells to the tumor microenvironment (TME) while enhancing susceptibility to anti-PD-1 mediated immune checkpoint therapy in multiple checkpoint blockade-resistant mouse models (72). Here, CD8A is linked to neoplasm.